-+ 0.00%
-+ 0.00%
-+ 0.00%

ULTRAGENYX COMPLETES ROLLING SUBMISSION OF BIOLOGICS LICENSE APPLICATION (BLA) TO U.S. FDA FOR DTX401 AAV GENE THERAPY FOR GLYCOGEN STORAGE DISEASE TYPE IA (GSDIA)

路透·12/30/2025 21:05:00

登錄查看新聞詳情